These mice constitutively express human c-MYC under the control of the murine Eμ enhancer throughout B cell development leading to increased expansion of B cell progenitors that subsequently transform into lymphoma following the acquisition of cooperating oncogenic mutations [4–6]. The gene discussed is MYC; the disease is lymphoma.